These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22126905)

  • 21. Synergistic and attenuated effect of HSS in combination treatment with docetaxel plus cisplatin in human non-small-cell lung SPC-A-1 tumor xenograft.
    Jia Y; Zhou D; Jia Q; Ying Y; Chen S
    Biomed Pharmacother; 2016 Apr; 79():27-34. PubMed ID: 27044809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
    Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
    Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.
    Fulzele SV; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2006 Mar; 58(3):327-36. PubMed ID: 16536899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin.
    Saha A; Kuzuhara T; Echigo N; Suganuma M; Fujiki H
    Cancer Prev Res (Phila); 2010 Aug; 3(8):953-62. PubMed ID: 20606042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
    Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
    Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
    Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery.
    Zheng D; Li D; Lu X; Feng Z
    Oncol Rep; 2010 Mar; 23(3):717-24. PubMed ID: 20127011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
    Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
    Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin.
    Hu L; Pang S; Hu Q; Gu D; Kong D; Xiong X; Su J
    Biomed Pharmacother; 2015 Oct; 75():26-32. PubMed ID: 26463628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effect of docetaxel and cisplatin for non-small cell lung cancer cell lines in vitro.
    Wang H
    Nagoya J Med Sci; 2000 Nov; 63(3-4):129-37. PubMed ID: 11201987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft.
    Kong M; Fan J; Dong A; Cheng H; Xu R
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer.
    Fizazi K; Sikes CR; Kim J; Yang J; Martinez LA; Olive MC; Logothetis CJ; Navone NM
    Anticancer Res; 2004; 24(5A):2897-903. PubMed ID: 15517894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling.
    Yin H; Zhou Y; Wen C; Zhou C; Zhang W; Hu X; Wang L; You C; Shao J
    Oncol Rep; 2014 Oct; 32(4):1610-6. PubMed ID: 25050915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.
    Kuo WT; Tu DG; Chiu LY; Sheu GT; Wu MF
    Oncol Rep; 2017 Nov; 38(5):2787-2795. PubMed ID: 28901493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vive distribution in nude mice.
    Qin Y; Song QG; Zhang ZR; Liu J; Fu Y; He Q; Liu J
    Arzneimittelforschung; 2008; 58(10):529-34. PubMed ID: 19025064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
    Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
    Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model.
    Marostica LL; de Barros ALB; Oliveira J; Salgado BS; Cassali GD; Leite EA; Cardoso VN; Lang KL; Caro MSB; Durán FJ; Schenkel EP; de Oliveira MC; Simões CMO
    Toxicol Appl Pharmacol; 2017 Aug; 329():272-281. PubMed ID: 28610991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma.
    Zhao J; Li QQ; Zou B; Wang G; Li X; Kim JE; Cuff CF; Huang L; Reed E; Gardner K
    Int J Oncol; 2007 Aug; 31(2):241-52. PubMed ID: 17611679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.